Clinical Review

Translating AHA/ACC cholesterol guidelines into meaningful risk reduction

Author:: Cezary Wójcik, MD, PhD, FNLA; Michael D. Shapiro, DO, FACC, FASPC, FNLA

The new recommendations detail refined, personalized lipid management and emphasize multiple levels of evidence. The result? Care is more complex...

The evidence is mixed, and the benefits are uncertain.

Patient age, baseline cardiovascular disease risk, bleeding risk, and personal preference regarding aspirin use are key to decision making. A...

Author:: Tate M. Johnson, MD; Ted R. Mikuls, MD, MSPH; Bryant R. England, MD

Author:: Susan Hatters Friedman, MD; Chandni Prakash, MBBS, MD; Sarah Nagle-Yang, MD

Urgent identification and treatment are needed to prevent potentially fatal consequences.

Author:: Bryan Zoll; Asad Jehangir, MD; Zubair Malik, MD; Michael A. Edwards, MD; Roman V. Petrov, MD; Henry P. Parkman, MD

Author:: Tate M. Johnson, MD; Ted R. Mikuls, MD, MSPH; Bryant R. England, MD

Certain agents may mitigate pain associated with neuropathy, fibromyalgia, headache, and IBS.

Author:: Kathryn McGrath, MD; Allison Rague, MD; Claire Thesing, MD; Elizabeth Collins, MD; Olivia Seecof, MD; John Liantonio, MD

Beyond tried-and-true therapies are new therapeutic targets on the horizon—giving you a bigger toolbox to help patients abort and prevent migraine...